catalog number :
MBS421184
products full name :
Goat anti-NCF1/p47phox Antibody
products short name :
NCF1/p47phox
products name syn :
Goat Anti-p47phox (mouse) Antibody; NCF1; p47phox; FLJ79451; NCF1A; NOXO2; SH3PXD1A; neutrophil cytosolic factor 1; Neutrophil cytosolic factor-1 (47kD); neutrophil cytosolic factor 1 (47kD, chronic granulomatous disease, autosomal 1); NADPH oxidase organizer 2; NCF1 antibody; p47phox antibody; FLJ79451 antibody; NCF1A antibody; NOXO2 antibody; SH3PXD1A antibody; neutrophil cytosolic factor 1 antibody; Neutrophil cytosolic factor-1 (47kD) antibody; neutrophil cytosolic factor 1 (47kD; chronic granulomatous disease; autosomal 1) antibody; NADPH oxidase organizer 2 antibody; NCF1 / p47phox
other names :
neutrophil cytosol factor 1; Neutrophil cytosol factor 1; neutrophil cytosol factor 1; neutrophil cytosolic factor 1; 47 kDa autosomal chronic granulomatous disease protein; 47 kDa neutrophil oxidase factor; NCF-47K; Neutrophil NADPH oxidase factor 1; Nox organizer 2; Nox-organizing protein 2; SH3 and PX domain-containing protein 1A; p47-phox
products gene name :
NCF1
products gene name syn :
p47phox
other gene names :
NCF1; NCF1; NCF1A; NOXO2; p47phox; SH3PXD1A; NOXO2; SH3PXD1A; NCF-1
uniprot entry name :
NCF1_HUMAN
reactivity :
Tested: Human, Mouse, Pig; Expected from sequence similarity: Human, Mouse, Rat, Rabbit, Pig, Cow
purity :
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide
form :
Supplied at 0.5 mg/ml in Tris saline, 0. 02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
concentration :
100ug specific antibody in 200ul
storage stability :
Aliquot and store at -20 degree C. Minimize freezing and thawing.
tested application :
Peptide ELISA (EIA), Western Blot (WB)
app notes :
Peptide ELISA: Antibody detection limit dilution 1: 20000. Western Blot: Approx 48kDa band observed in lysates of cell line U937 and of Mouse Thymus, and 50kDa observed in Pig Spleen lysates (calculated MW of 44.7kDa according to NP_000256.3). Recommended concentration: 0.5-1.5ug/ml.
other info1 :
Immunogen: Peptide with sequence C-SESTKRKLASAV, from the C Terminus of the protein sequence according to NP_000256.3. Epitope: C Terminus
ncbi acc num :
NP_000256.3
ncbi gb acc num :
NM_000265.4
ncbi mol weight :
30,781 Da
ncbi pathways :
AGE/RAGE Pathway (698754); Adaptive Immune System Pathway (1269171); Antigen Processing-Cross Presentation Pathway (1269195); Chemokine Signaling Pathway (99051); Chemokine Signaling Pathway (96864); Class I MHC Mediated Antigen Processing Presentation Pathway (1269192); Cross-presentation Of Particulate Exogenous Antigens (phagosomes) Pathway (1269196); Fc Gamma R-mediated Phagocytosis Pathway (114228); Fc Gamma R-mediated Phagocytosis Pathway (106590); Immune System Pathway (1269170)
ncbi summary :
The protein encoded by this gene is a 47 kDa cytosolic subunit of neutrophil NADPH oxidase. This oxidase is a multicomponent enzyme that is activated to produce superoxide anion. Mutations in this gene have been associated with chronic granulomatous disease. [provided by RefSeq, Jul 2008]
uniprot summary :
p47phox: the 47-kilodalton cytosolic subunit of the multi-protein complex known as NADPH oxidase found in neutrophils. The holo-oxidase produces a burst of superoxide which is delivered to the lumen of the neutrophil phagosome. Contains 2 SH2 domains. Mutations in NCF1, as well as in other NADPH oxidase subunits, can result in chronic granulomatous disease. Protein type: EC 1.-.-.-; Oxidoreductase. Chromosomal Location of Human Ortholog: 7q11.23. Cellular Component: cytosol; extrinsic to membrane; NADPH oxidase complex. Molecular Function: electron carrier activity; phosphatidylinositol-3,4-bisphosphate binding; phosphoinositide binding; protein binding; SH3 domain binding; superoxide-generating NADPH oxidase activity. Biological Process: antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; cell redox homeostasis; cellular defense response; innate immune response; protein targeting to membrane; respiratory burst; superoxide metabolic process; superoxide release; vascular endothelial growth factor receptor signaling pathway. Disease: Granulomatous Disease, Chronic, Autosomal Recessive, Cytochrome B-positive, Type I